Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barré syndrome and downregulated by IVIg treatments.
about
Double Roles of Macrophages in Human Neuroimmune Diseases and Their Animal ModelsBiomarkers of Guillain-Barré Syndrome: Some Recent Progress, More Still to Be ExploredThe Newly Identified T Helper 22 Cells Lodge in LeukemiaRegulatory T cells in multiple sclerosis and myasthenia gravis.Th17 Pathway As a Target for Multipotent Stromal Cell Therapy in Dogs: Implications for Translational Research.Plasma Prostaglandin E2 Levels Correlated with the Prevention of Intravenous Immunoglobulin Resistance and Coronary Artery Lesions Formation via CD40L in Kawasaki Disease.Circulating memory T follicular helper subsets, Tfh2 and Tfh17, participate in the pathogenesis of Guillain-Barré syndrome.Monomeric Immunoglobulin A from Plasma Inhibits Human Th17 Responses In Vitro Independent of FcαRI and DC-SIGN.T cell epitope redundancy: cross-conservation of the TCR face between pathogens and self and its implications for vaccines and autoimmunity.Intravenous immunoglobulin: pharmacological properties and use in polyneuropathies.Immune camouflage: relevance to vaccines and human immunology.Disturbance of Plasma Lipid Metabolic Profile in Guillain-Barre Syndrome.Immune dysregulation in patients with carpal tunnel syndrome.Probiotics as a Potential Alternative for Relieving Peripheral Neuropathies: a Case for Guillain-Barré Syndrome.Novel pathomechanisms in inflammatory neuropathies.IL-22 Impedes the Proliferation of Schwann cells: Transcriptome Sequencing and Bioinformatics Analysis.Polymorphisms of IL-17 and ICAM-1 and their expression in Guillain-Barré syndrome.Intravenous immunoglobulin exerts reciprocal regulation of Th1/Th17 cells and regulatory T cells in Guillain–Barré syndrome patients
P2860
Q26749131-CA17A9FF-96C9-4783-A4E0-6FDA6D25E107Q26785669-C16A44AA-8E4E-4FF4-B2CB-A3593660751DQ26799454-3D57DEEC-05D3-42FA-BFF0-00AF8B65E32CQ33784969-BF02767C-C2A5-492C-AE91-E2E28AD34FECQ35922408-A547FDB4-6918-4131-B270-E8E4BD70DC8FQ36104063-60D3F49A-AB24-471F-A680-6703D034BDAEQ36569933-61111407-4E35-4353-BE01-4A2D09A744A8Q37698474-D93420BE-A30F-4AA6-99C0-1E1692005751Q38640293-45A3DA9D-9036-44CA-8EFA-73965512D260Q38900642-37762127-B6EA-47A4-81C2-63F0075473F9Q39080439-B6C54C66-1810-4A4C-850D-ABC6BD4EAC99Q41419380-27B0A583-A3CC-4EC7-BE85-24B1926CFDA8Q41423404-16E7C89C-8BC8-4586-9F0D-30729120C693Q43102305-DB17EFD6-2DCB-4EE3-8B1F-A1EF7A8EA1B9Q47126672-11766F67-3A30-431A-B01F-EEB12714C0B3Q52881492-95A561C4-AA8E-40D1-BC42-605CB933E415Q54144878-55B53DC7-ECF1-40AE-B9A9-E395D0883CF6Q58861212-664DA3A8-CD0C-4AC3-B854-B3A2CD212CEE
P2860
Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barré syndrome and downregulated by IVIg treatments.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Circulating Th17, Th22, and Th ...... nregulated by IVIg treatments.
@ast
Circulating Th17, Th22, and Th ...... nregulated by IVIg treatments.
@en
type
label
Circulating Th17, Th22, and Th ...... nregulated by IVIg treatments.
@ast
Circulating Th17, Th22, and Th ...... nregulated by IVIg treatments.
@en
prefLabel
Circulating Th17, Th22, and Th ...... nregulated by IVIg treatments.
@ast
Circulating Th17, Th22, and Th ...... nregulated by IVIg treatments.
@en
P2093
P2860
P356
P1476
Circulating Th17, Th22, and Th ...... wnregulated by IVIg treatments
@en
P2093
Fanhua Meng
Hernan Concha Quezada
Hong-Liang Zhang
Shujuan Li
P2860
P304
P356
10.1155/2014/740947
P50
P577
2014-05-12T00:00:00Z